IP Library › Granted Patent US 12,653,669
Granted Patent B2
US 12,653,669 · App. 18/618,560 · Granted Jun 16, 2026

Geometrically-accommodating heart valve replacement device

Inventors: Sophie-Charlotte Hofferberth (Boston, MA); Pedro J. del Nido (Lexington, MA); Mossab Y. Saeed (Revere, MA)
Assignee: The Children's Medical Center Corporation
A61F2/2418A61F2/2412A61F2/243A61F2220/0075A61F2250/001A61F2250/0029A61F2250/0051A61F2250/006A61F2250/0069A61F2250/0082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,653,669
App. No.
18/618,560
Granted
Jun 16, 2026
Kind
B2
Abstract

A replacement heart valve device is disclosed. In some embodiments, the device includes a frame coupled to one or more leaflets that are moveable between open and closed configurations. In some embodiments, the frame comprises at least two frame sections that join at a pair of commissural posts. In some embodiments, the device may be geometrically accommodating to adapt to different vasculature shapes and sizes and/or to be able to change size while implanted within a growing patient.

Claims (31)

1 . A valve replacement device, comprising:

a valve frame comprising first and second U-shaped frame sections connected at one end by a pair of commissures, the valve frame defining an opening for the passage of fluid, the first and second frame sections each having first and second arms, the valve frame being expandable to permit an increase in a diameter of the opening over a diameter size range of the opening;

a valve leaflet coupled to the valve frame, the valve leaflet having an open configuration in which the opening is exposed, and a closed configuration in which the valve leaflet at least partially covers the opening, wherein the valve leaflet is configured to be moveable between the open and closed configurations over the diameter size range of the opening; and

a sleeve coupled to the valve frame, the sleeve having a first expandable direction orientated to permit the increase in the diameter of the opening of the valve frame,

wherein the sleeve further comprises a film, wherein the film is configured to minimize native tissue ingrowth into the sleeve.

2 . The valve replacement device of claim 1 , wherein the film is on an exterior of the sleeve.

3 . The valve replacement device of claim 1 , wherein the film has a tighter microstructure than the rest of the sleeve.

4 . The valve replacement device of claim 1 , wherein the sleeve comprises a first sleeve portion and a second sleeve portion coupled to the valve frame.

5 . The valve replacement device of claim 4 ,

wherein the first and second sleeve portions are constructed from sections of tube graft, the sections of tube graft having a longitudinal direction, and

wherein the first expandable direction of the sleeve is the longitudinal direction of the sections of tube graft.

6 . The valve replacement device of claim 1 , wherein a proximal end of the sleeve is configured for suture fixation to native structures.

7 . The valve replacement device of claim 1 , wherein the valve frame is expandable to permit an increase in the diameter of the opening past a functional range of the valve leaflet in order to configure the valve replacement device as a pre-stent for a transcatheter valve-in-valve replacement procedure.

8 . The valve replacement device of claim 1 , wherein the valve frame is expandable to permit the increase in the diameter of the opening to be greater than 22 mm.

9 . The valve replacement device of claim 1 , wherein the valve leaflet is configured to maintain a constant surface area with expansion of the valve frame.

10 . The valve replacement device of claim 1 ,

wherein the valve frame has a plurality of holes through the valve frame,

wherein the valve leaflet comprises a first leaflet and a second leaflet,

wherein the first leaflet has an outer edge, and is coupled to the valve frame using at least some of the plurality of holes through the valve frame, and the second leaflet has an outer edge, and is coupled to the valve frame using at least some of the plurality of holes through the valve frame,

wherein the first and second leaflets have a plurality of leaflet attachment points for coupling the first and second leaflets to the valve frame, and

wherein the plurality of leaflet attachment points are located a non-uniform distance from the outer edges of the first and second leaflets.

11 . The valve replacement device of claim 10 ,

wherein the plurality of holes are through the first and second U-shaped frame sections and through the pair of commissures,

wherein the first leaflet is coupled to the holes in the first U-shaped frame section and the pair of commissures, and

wherein the second leaflet is coupled to the holes in the second U-shaped frame section and the pair of commissures.

12 . The valve replacement device of claim 11 ,

further comprising a first reinforcement feature that connects the pairs of commissures,

further comprising a second reinforcement feature that connects the first and second U-shaped frame sections, and

wherein the first reinforcement feature is of a different shape than the second reinforcement feature.

13 . The valve replacement device of claim 1 , wherein the valve frame includes a plurality of holes through the valve frame, wherein the valve leaflet is coupled to the valve frame using at least some of the plurality of holes through the valve frame, and wherein the sleeve is coupled to the valve frame using at least some of the plurality of holes through the valve frame.

14 . The valve replacement device of claim 1 , wherein the sleeve is formed from ePTFE.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2024
From: HOFFERBERTH, SOPHIE-CHARLOTTE; DEL NIDO, PEDRO J.; SAEED, MOSSAB Y.
To: THE CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 067151/0117 →
Continuity (3)
Continuation 18351785 · Jul 13, 2023
Provisional Application 63394742 · Aug 3, 2022
Related Publication 20240315837A1 · Sep 26, 2024
References Cited (40)
US 10932904B2 · Lee et al. · 2021 [cited by applicant]
US 10966826B2 · Hofferberth et al. · 2021 [cited by applicant]
US 11376123B2 · Gründeman et al. · 2022 [cited by applicant]
US 11969342B2 · Hofferberth et al. · 2024 [cited by applicant]
US 12004948B2 · Hofferberth et al. · 2024 [cited by applicant]
US 20030014104A1 · Cribier · 2003 [cited by applicant]
US 20040260389A1 · Case et al. · 2004 [cited by applicant]
US 20050075584A1 · Cali · 2005 [cited by applicant]
US 20070288087A1 · Fearnot et al. · 2007 [cited by applicant]
US 20090054973A1 · Johnson · 2009 [cited by applicant]
US 20090254176A1 · Butera · 2009 [cited by applicant]
US 20110098802A1 · Braido et al. · 2011 [cited by applicant]
US 20120101571A1 · Thambar et al. · 2012 [cited by applicant]
US 20130018453A1 · Case et al. · 2013 [cited by applicant]
US 20160000567A1 · Melzer et al. · 2016 [cited by applicant]
US 20160158013A1 · Carpentier et al. · 2016 [cited by applicant]
US 20160220361A1 · Weber et al. · 2016 [cited by applicant]
US 20170014228A1 · Emani et al. · 2017 [cited by applicant]
US 20170065411A1 · Grundeman et al. · 2017 [cited by applicant]
US 20170095331A1 · Spenser et al. · 2017 [cited by applicant]
US 20170189175A1 · Justino et al. · 2017 [cited by applicant]
US 20170252156A1 · Bernstein et al. · 2017 [cited by applicant]
US 20170333188A1 · Carpentier et al. · 2017 [cited by applicant]
US 20190105153A1 · Barash · 2019 [cited by examiner]
US 20200360135A1 · Hofferberth et al. · 2020 [cited by applicant]
US 20200368017A1 · Hofferberth et al. · 2020 [cited by applicant]
US 20210322162A1 · Tayeb · 2021 [cited by examiner]
US 20210330457A1 · Colavito et al. · 2021 [cited by applicant]
US 20210353443A1 · King et al. · 2021 [cited by applicant]
US 20220008233A1 · Nia · 2022 [cited by examiner]
US 20230225862A1 · Yohanan et al. · 2023 [cited by applicant]
US 20230270540A1 · Schwartz · 2023 [cited by examiner]
US 20240041595A1 · Hofferbeth et al. · 2024 [cited by applicant]
US 20240358502A1 · Hofferberth et al. · 2024 [cited by applicant]
WO WO9904730A1 · 1999 [cited by applicant]
WO WO2012018779A3 · 2012 [cited by applicant]
WO WO2019099864A1 · 2019 [cited by applicant]
WO WO2019099864A8 · 2019 [cited by applicant]
International Search Report and Written Opinion mailed Dec. 4, 2023, in connection with International Application No. PCT/US2023/027599. [cited by applicant]
Invitation to Pay Additional Fees mailed Oct. 11, 2023, in connection with International Application No. PCT/US2023/027599. [cited by applicant]